EMA and the European Commission revise Q&A document on implementation of marketing authorization guidelines. The European Medicines Agency (EMA), in agreement with the European Commission, has ...

New guidelines aim to streamline lifecycle management and adapt to scientific and technological advancements in drug development. Variations are classified into Type IA, Type IB, and Type II based on ...

The European Medicines Agency (EMA), in agreement with the European Commission, has released an updated question and answer document clarifying a number of issues related to the new categories of ...